Precision Medicine
Proton & Heavy Ion Therapy
Target tumors with sub-millimeter accuracy while sparing healthy tissue. Our partner facilities in Shanghai and Gansu offer some of the world's most advanced particle therapy systems, ideal for treating sensitive cancers in the brain, eye, and pediatric cases.
- Shanghai Proton and Heavy Ion Center (SPHIC)
- Wuwei Heavy Ion Center (Gansu)
- Non-invasive treatment with minimal side effects
- Ideal for radio-resistant tumors
CAR-T Cell Therapy
A revolutionary treatment for relapsed or refractory blood cancers (Leukemia, Lymphoma, Myeloma). China is a global leader in CAR-T clinical trials, offering access to dual-target therapies often unavailable elsewhere.
- Rapid manufacturing (vein-to-vein in ~14 days)
- Cost-effective (1/4 to 1/3 of US prices)
- Novel targets (CD19, CD22, BCMA) available
Multi-disciplinary Team (MDT) Approach
Cancer care is never one-size-fits-all. We ensure your case is reviewed by a collaborative board of experts—surgeons, oncologists, radiologists, and pathologists—from China's top Grade-A hospitals to formulate the most effective, personalized treatment plan.
Comprehensive Review
Every aspect of your pathology and history is analyzed by specialists.
Collaborative Planning
Experts debate and agree on the optimal sequence of therapies.
Top-Tier Partnerships
Direct access to specialists from National Top-Ranked General Hospital, Leading Hematology Center, and more.